Board Meeting Details
- Meeting scheduled for Wednesday, 4th November, 2026
- Agenda includes consideration and transaction of specified business items
Agenda Items
1. Consideration and approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report of the Statutory Auditors
2. Consideration and approval of change of Registrar and Share Transfer Agent (RTA) of the Company, subject to applicable regulatory and other approvals where required
3. Discussion and approval of initial proposal for fund raising through issuance and allotment of Securities (Equity/Warrants) via Preferential Issue, Right Issue, or other mode
4. Consideration of any other matter with permission of the Chair
Trading Window Closure
In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives until 48 hours after the declaration of the financial results for the quarter and half-year ended September 30, 2026.
Financial Impact
Financial impact not quantified in the disclosure. The fund raising proposal and RTA change may have future financial implications subject to board approval and regulatory compliance.